Analysis of networks in the dorsolateral prefrontal cortex in chronic schizophrenia: Relevance of altered immune response
The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatogra...
Saved in:
| Published in | Frontiers in pharmacology Vol. 14; p. 1003557 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media S.A
23.03.2023
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1663-9812 1663-9812 |
| DOI | 10.3389/fphar.2023.1003557 |
Cover
| Abstract | The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatography-tandem mass spectrometry of grey matter of postmortem DLPFC in chronic schizophrenia subjects (n = 20) and unaffected subjects (n = 20) followed by bioinformatic analysis to identify altered protein networks in schizophrenia (PXD024939 identifier in ProteomeXchange repository). Our results displayed a proteome profile in the DLPFC of 1989 proteins. 43 proteins were found significantly altered in schizophrenia. Analysis of this panel showed an enrichment of biological processes implicated in vesicle-mediated transport, processing and antigen presentation
via
MHC class II, intracellular transport and selenium metabolism. The enriched identified pathways were MHC class II antigen presentation, vesicle-mediated transport, Golgi ER retrograde transport, Nef mediated CD8 downregulation and the immune system. All these enriched categories were found to be downregulated. Furthermore, our network analyses showed crosstalk between proteins involved in MHC class II antigen presentation, membrane trafficking, Golgi-to-ER retrograde transport, Nef-mediated CD8 downregulation and the immune system with only one module built by 13 proteins. RAB7A showed eight interactions with proteins of all these pathways. Our results provide an altered molecular network involved in immune response in the DLPFC in schizophrenia with a central role of RAB7A. These results suggest that RAB7A or other proteins of this network could be potential targets for novel pharmacological strategies in schizophrenia for improving cognitive and negative symptoms. |
|---|---|
| AbstractList | The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatography-tandem mass spectrometry of grey matter of postmortem DLPFC in chronic schizophrenia subjects (n = 20) and unaffected subjects (n = 20) followed by bioinformatic analysis to identify altered protein networks in schizophrenia (PXD024939 identifier in ProteomeXchange repository). Our results displayed a proteome profile in the DLPFC of 1989 proteins. 43 proteins were found significantly altered in schizophrenia. Analysis of this panel showed an enrichment of biological processes implicated in vesicle-mediated transport, processing and antigen presentation
MHC class II, intracellular transport and selenium metabolism. The enriched identified pathways were MHC class II antigen presentation, vesicle-mediated transport, Golgi ER retrograde transport, Nef mediated CD8 downregulation and the immune system. All these enriched categories were found to be downregulated. Furthermore, our network analyses showed crosstalk between proteins involved in MHC class II antigen presentation, membrane trafficking, Golgi-to-ER retrograde transport, Nef-mediated CD8 downregulation and the immune system with only one module built by 13 proteins. RAB7A showed eight interactions with proteins of all these pathways. Our results provide an altered molecular network involved in immune response in the DLPFC in schizophrenia with a central role of RAB7A. These results suggest that RAB7A or other proteins of this network could be potential targets for novel pharmacological strategies in schizophrenia for improving cognitive and negative symptoms. The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatography-tandem mass spectrometry of grey matter of postmortem DLPFC in chronic schizophrenia subjects (n = 20) and unaffected subjects (n = 20) followed by bioinformatic analysis to identify altered protein networks in schizophrenia (PXD024939 identifier in ProteomeXchange repository). Our results displayed a proteome profile in the DLPFC of 1989 proteins. 43 proteins were found significantly altered in schizophrenia. Analysis of this panel showed an enrichment of biological processes implicated in vesicle-mediated transport, processing and antigen presentation via MHC class II, intracellular transport and selenium metabolism. The enriched identified pathways were MHC class II antigen presentation, vesicle-mediated transport, Golgi ER retrograde transport, Nef mediated CD8 downregulation and the immune system. All these enriched categories were found to be downregulated. Furthermore, our network analyses showed crosstalk between proteins involved in MHC class II antigen presentation, membrane trafficking, Golgi-to-ER retrograde transport, Nef-mediated CD8 downregulation and the immune system with only one module built by 13 proteins. RAB7A showed eight interactions with proteins of all these pathways. Our results provide an altered molecular network involved in immune response in the DLPFC in schizophrenia with a central role of RAB7A. These results suggest that RAB7A or other proteins of this network could be potential targets for novel pharmacological strategies in schizophrenia for improving cognitive and negative symptoms.The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatography-tandem mass spectrometry of grey matter of postmortem DLPFC in chronic schizophrenia subjects (n = 20) and unaffected subjects (n = 20) followed by bioinformatic analysis to identify altered protein networks in schizophrenia (PXD024939 identifier in ProteomeXchange repository). Our results displayed a proteome profile in the DLPFC of 1989 proteins. 43 proteins were found significantly altered in schizophrenia. Analysis of this panel showed an enrichment of biological processes implicated in vesicle-mediated transport, processing and antigen presentation via MHC class II, intracellular transport and selenium metabolism. The enriched identified pathways were MHC class II antigen presentation, vesicle-mediated transport, Golgi ER retrograde transport, Nef mediated CD8 downregulation and the immune system. All these enriched categories were found to be downregulated. Furthermore, our network analyses showed crosstalk between proteins involved in MHC class II antigen presentation, membrane trafficking, Golgi-to-ER retrograde transport, Nef-mediated CD8 downregulation and the immune system with only one module built by 13 proteins. RAB7A showed eight interactions with proteins of all these pathways. Our results provide an altered molecular network involved in immune response in the DLPFC in schizophrenia with a central role of RAB7A. These results suggest that RAB7A or other proteins of this network could be potential targets for novel pharmacological strategies in schizophrenia for improving cognitive and negative symptoms. The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatography-tandem mass spectrometry of grey matter of postmortem DLPFC in chronic schizophrenia subjects (n = 20) and unaffected subjects (n = 20) followed by bioinformatic analysis to identify altered protein networks in schizophrenia (PXD024939 identifier in ProteomeXchange repository). Our results displayed a proteome profile in the DLPFC of 1989 proteins. 43 proteins were found significantly altered in schizophrenia. Analysis of this panel showed an enrichment of biological processes implicated in vesicle-mediated transport, processing and antigen presentation via MHC class II, intracellular transport and selenium metabolism. The enriched identified pathways were MHC class II antigen presentation, vesicle-mediated transport, Golgi ER retrograde transport, Nef mediated CD8 downregulation and the immune system. All these enriched categories were found to be downregulated. Furthermore, our network analyses showed crosstalk between proteins involved in MHC class II antigen presentation, membrane trafficking, Golgi-to-ER retrograde transport, Nef-mediated CD8 downregulation and the immune system with only one module built by 13 proteins. RAB7A showed eight interactions with proteins of all these pathways. Our results provide an altered molecular network involved in immune response in the DLPFC in schizophrenia with a central role of RAB7A. These results suggest that RAB7A or other proteins of this network could be potential targets for novel pharmacological strategies in schizophrenia for improving cognitive and negative symptoms. The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. We performed a proteomic analysis using single-shot liquid chromatography-tandem mass spectrometry of grey matter of postmortem DLPFC in chronic schizophrenia subjects (n = 20) and unaffected subjects (n = 20) followed by bioinformatic analysis to identify altered protein networks in schizophrenia (PXD024939 identifier in ProteomeXchange repository). Our results displayed a proteome profile in the DLPFC of 1989 proteins. 43 proteins were found significantly altered in schizophrenia. Analysis of this panel showed an enrichment of biological processes implicated in vesicle-mediated transport, processing and antigen presentation via MHC class II, intracellular transport and selenium metabolism. The enriched identified pathways were MHC class II antigen presentation, vesicle-mediated transport, Golgi ER retrograde transport, Nef mediated CD8 downregulation and the immune system. All these enriched categories were found to be downregulated. Furthermore, our network analyses showed crosstalk between proteins involved in MHC class II antigen presentation, membrane trafficking, Golgi-to-ER retrograde transport, Nef-mediated CD8 downregulation and the immune system with only one module built by 13 proteins. RAB7A showed eight interactions with proteins of all these pathways. Our results provide an altered molecular network involved in immune response in the DLPFC in schizophrenia with a central role of RAB7A. These results suggest that RAB7A or other proteins of this network could be potential targets for novel pharmacological strategies in schizophrenia for improving cognitive and negative symptoms. |
| Author | Villén, Judit Vera-Montecinos, América Rodríguez-Mias, Ricard Vila, Èlia Ramos, Belén |
| AuthorAffiliation | 5 Facultat de Medicina , Universitat de Vic-Universitat Central de Catalunya , Vic , Spain 3 Centro de Investigación Biomédica en Red de Salud Mental , CIBERSAM (Biomedical Network Research Center of Mental Health) , Ministry of Economy, Industry and Competitiveness , Institute of Health Carlos III , Madrid , Spain 1 Psiquiatria Molecular , Parc Sanitari Sant Joan de Déu , Institut de Recerca Sant Joan de Déu , Sant Boi de Llobregat , Spain 2 Department of Genome Sciences , School of Medicine , University of Washington , Seattle , WA , United States 4 Department de Bioquímica i Biología Molecular , Facultat de Medicina , Universitat Autònoma de Barcelona , Barcelona , Spain |
| AuthorAffiliation_xml | – name: 3 Centro de Investigación Biomédica en Red de Salud Mental , CIBERSAM (Biomedical Network Research Center of Mental Health) , Ministry of Economy, Industry and Competitiveness , Institute of Health Carlos III , Madrid , Spain – name: 2 Department of Genome Sciences , School of Medicine , University of Washington , Seattle , WA , United States – name: 4 Department de Bioquímica i Biología Molecular , Facultat de Medicina , Universitat Autònoma de Barcelona , Barcelona , Spain – name: 1 Psiquiatria Molecular , Parc Sanitari Sant Joan de Déu , Institut de Recerca Sant Joan de Déu , Sant Boi de Llobregat , Spain – name: 5 Facultat de Medicina , Universitat de Vic-Universitat Central de Catalunya , Vic , Spain |
| Author_xml | – sequence: 1 givenname: América surname: Vera-Montecinos fullname: Vera-Montecinos, América – sequence: 2 givenname: Ricard surname: Rodríguez-Mias fullname: Rodríguez-Mias, Ricard – sequence: 3 givenname: Èlia surname: Vila fullname: Vila, Èlia – sequence: 4 givenname: Judit surname: Villén fullname: Villén, Judit – sequence: 5 givenname: Belén surname: Ramos fullname: Ramos, Belén |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37033658$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhiNUREvpH-CAcuSyi2PHjs0FVRUflSohIThbE3vSuGTtYHsLy6_H6S5VywFfPBq_88zI8z6vjnzwWFUvG7JmTKo3wzxCXFNC2bohhHHePalOGiHYSsmGHj2Ij6uzlG5IOUwpJtpn1THrCGOCy5Nqd-5h2iWX6jDUHvPPEL-n2vk6j1jbEFOYIGOEqZ4jDjH4XEITYsZfi8qMJeVMnczofod5jOgdvK2_4IS34A0uVJgKAG3tNputxzpimoNP-KJ6OsCU8Oxwn1bfPrz_evFpdfX54-XF-dXKtELlFVdtr6QF2rZgiBJgmg5Fr2iD1NDG9mQQnaSt5YwgyKHhA4ARhMvBdr2w7LS63HNtgBs9R7eBuNMBnL5LhHitIWZnJtRcKAusZ7ZrZUtBguW9aS1VHIkY-raw3u1Z87bfoDXoc_maR9DHL96N-jrc6rKiTgguCuH1gRDDjy2mrDcuGZwm8Bi2SdNOqUaoTi3SVw-b3Xf5u7wioHuBiSGlsp57SUP0YhJ9ZxK9mEQfTFKK5D9FxmXILiwDu-l_pX8AhLPGZA |
| CitedBy_id | crossref_primary_10_1038_s41537_024_00518_5 |
| Cites_doi | 10.1126/science.1260419 10.1016/j.schres.2009.07.025 10.1242/jcs.01114 10.15252/msb.20145625 10.3389/fnmol.2020.597391 10.3389/fpsyt.2018.00767 10.3389/fnins.2015.00397 10.1038/nmeth.3901 10.1016/j.tins.2012.08.001 10.1073/pnas.0502206102 10.1038/s41467-019-14122-0 10.1503/jpn.150195 10.1093/nar/gkt439 10.1176/appi.ajp.2008.07060945 10.1083/jcb.147.2.307 10.1016/s0960-9822(02)01221-6 10.1038/nrn2648 10.1038/s41398-019-0472-z 10.1016/S1134-5934(08)71126-6 10.1038/s41537-020-0093-9 10.1176/appi.ajp.2009.09060802 10.1001/jamapsychiatry.2014.2414 10.1007/s00018-012-1021-6 10.1038/s41586-018-0761-3 10.1016/j.schres.2010.05.014 10.1001/archpsyc.1995.03950190026004 10.1074/jbc.R115.655118 10.3389/fncel.2020.00274 10.1038/s41398-022-02128-0 10.17691/STM2021.13.6.03 10.3389/fpsyt.2018.00753 10.1038/nn.2321 10.1007/s11920-016-0710-5 10.1016/s0006-3223(99)00061-x 10.1016/j.schres.2018.12.017 10.1016/s0920-9964(00)00156-0 10.1038/nature12929 10.1128/JVI.00926-07 10.1128/mcb.23.18.6494-6506.2003 10.1176/appi.ajp.157.12.2040 10.1186/s12974-021-02260-6 10.1038/s41380-021-01092-3 10.1111/j.2517-6161.1995.tb02031.x 10.1038/nature08186 10.1016/j.mehy.2009.09.040 10.1016/j.neuint.2018.09.010 10.1074/jbc.M105927200 10.1038/s41467-018-07053-9 10.1186/s13578-021-00543-2 10.1016/j.gpb.2019.10.003 10.5483/BMBRep.2019.52.5.097 10.1186/1471-2164-13-S8-S20 10.1007/978-0-387-30410-6_7 10.1016/j.biopsych.2006.12.021 10.2147/NDT.S225643 10.1038/sj.mp.4002098 10.1016/j.cub.2018.02.010 10.3389/fncel.2014.00081 10.1093/hmg/ddz253 10.15252/msb.20199021 10.1038/mp.2012.110 10.1038/mp.2014.63 10.1080/07853890.2020.1814962 10.1186/1471-2202-9-41 10.1002/glia.20232 10.1371/journal.ppat.1008821 10.1016/s0952-7915(01)00295-3 10.3389/fpsyt.2021.728990 10.1126/science.aaa4080 10.1038/mp.2015.90 10.1038/cddis.2016.467 10.1038/s41380-018-0235-x 10.1038/npp.2013.190 10.1038/ncomms11932 10.1176/appi.ajp.2009.09030361 10.1080/09540260701486365 10.3389/fnmol.2020.574947 10.1176/appi.ajp.161.5.889 10.1111/acps.13140 10.1016/j.pbb.2013.08.007 10.4321/s1886-36552007000100007 10.1016/j.jneuroim.2020.577167 10.1016/j.pnpbp.2017.08.005 10.1093/nar/30.1.163 10.1176/appi.ajp.2010.09081215 10.1093/schbul/sbz060 10.1016/j.neuron.2009.09.044 10.1038/nn804 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos. Copyright © 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos. 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos |
| Copyright_xml | – notice: Copyright © 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos. – notice: Copyright © 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos. 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fphar.2023.1003557 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Vera-Montecinos et al |
| EISSN | 1663-9812 |
| ExternalDocumentID | oai_doaj_org_article_569da3b3d74842a8ad5bc4d295e06fb4 PMC10076656 37033658 10_3389_fphar_2023_1003557 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; grantid: 72160426 – fundername: ; grantid: MS16/00153 CP16/00153 CPII21/00008 PI18/00213 FI19/00080 CIBERSAM – fundername: ; grantid: R35 GM119536 R01 NS098329 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c469t-594b98da244ac096ac17e6b921e2c21db0f67824d530ea8f15faac6058fd7b6d3 |
| IEDL.DBID | M48 |
| ISSN | 1663-9812 |
| IngestDate | Wed Aug 27 01:24:55 EDT 2025 Thu Aug 21 18:38:20 EDT 2025 Thu Sep 04 19:07:41 EDT 2025 Thu Jan 02 22:53:52 EST 2025 Thu Apr 24 23:07:05 EDT 2025 Tue Jul 01 02:53:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | immune system molecular network schizophrenia DLPFC postmortem |
| Language | English |
| License | Copyright © 2023 Vera-Montecinos, Rodríguez-Mias, Vila, Villén and Ramos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c469t-594b98da244ac096ac17e6b921e2c21db0f67824d530ea8f15faac6058fd7b6d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Luiz Felipe Souza E. Silva, University of São Paulo, Brazil Edited by: Javier R. Caso, Universidad Complutense de Madrid, Spain Reviewed by: Dibyadeep Datta, Yale University, United States This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2023.1003557 |
| PMID | 37033658 |
| PQID | 2799169796 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_569da3b3d74842a8ad5bc4d295e06fb4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10076656 proquest_miscellaneous_2799169796 pubmed_primary_37033658 crossref_primary_10_3389_fphar_2023_1003557 crossref_citationtrail_10_3389_fphar_2023_1003557 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-03-23 |
| PublicationDateYYYYMMDD | 2023-03-23 |
| PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-23 day: 23 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pharmacology |
| PublicationTitleAlternate | Front Pharmacol |
| PublicationYear | 2023 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Re (B68) 2001; 276 van Berlekom (B88) 2020; 46 Kouneiher (B44) 2009; 12 Elmer (B22) 2012; 35 Short (B78) 2002; 12 Abekhoukh (B1) 2014; 8 Arnsten (B4) 2009; 10 Brown (B10) 2010; 167 Mueller (B60) 2020; 6 Hall (B31) 2020; 29 Logue (B52) 2014; 123 Palesch (B36) 2020; 16 O’Donnell (B62) 1995; 52 Zhang (B95) 2019; 52 Mukai (B61) 2016; 7 Wang (B89) 2013; 41 Arion (B3) 2007; 62 Malashenkova (B56) 2021; 13 Tyanova (B84) 2016; 13 Uhlén (B85) 1979; 347 Correll (B18) 2020; 16 Hiltbold (B34) 2002; 14 Fernandez-Egea (B23) Gardner (B29) 2010; 167 Larsen (B47) 2022; 12 Spence (B81) 2015; 290 Rasika (B67) 2019 MacDowell (B54) 2017; 79 Brown (B11) 2004; 161 Bondy (B6) 2020; 340 Cai (B12) 2020; 25 Childers (B15) García-Bueno (B28) 2016; 41 Smolders (B80) 2018; 9 Zhao (B96) Karageorgiou (B41) 2019; 206 Shankar (B76) 2007; 5 Bauer (B5) 2010; 117 Kinney (B42) 2010; 74 Afia (B2) 2021; 18 Chew (B14) 2005; 52 Lu (B53) 2021; 11 Teffer (B83) 2012 Pennington (B64) 2008; 13 Egbujo (B20) 2016; 18 Kao (B40) 2009 Ridvan Kiral (B69) 2018; 28 Föcking (B26) 2015; 20 Hewett (B33) 2002; 30 Santarelli (B75) 2020; 17 Fromer (B27) 2014; 506 Kowalski (B45) 2001; 50 Comer (B16) 2020; 14 McCormick (B57) 2005; 102 Roca (B70) 2008; 15 Kroken (B46) 2019; 10 Yoon (B91) 2008; 165 Meyer-Lindenberg (B58) 2002; 5 Borrajo (B7) 2021; 53 Hughes (B35) 2014; 10 Onwordi (B63) 2020; 11 Eckley (B19) 1999; 147 Gutierrez (B30) 2004; 117 Mueller (B59) 2014; 39 Pottorf (B65) 2018; 121 Yan (B90) 2021; 27 Tanaka (B82) 2008; 9 Ursu (B87) 2011; 168 Ellman (B21) 2010; 121 Shatz (B77) 2009; 64 Harrison (B32) 2003; 23 Sandberg (B74) 2021; 12 Wang (B43) 2020; 13 Jackson (B38) 2020; 142 Sami Saribas (B73) 2017; 8 Leutert (B48) 2019; 15 Zhang (B93) Ragland (B66) 2007; 19 Russell (B71) 2000; 157 Li (B50) 2019; 10 Urnavicius (B86) 1979; 347 B55 Liu (B51) 2012; 69 Consortium (B17) 2009; 460 Jaarsma (B37) 2015; 9 Bowen (B8) 2019; 9 Lewis (B49) 1999; 46 Fillman (B25) 2016; 21 Benjamini (B92) 1995; 57 Sacha (B72) 2007; 81 Jourquin (B39) 2012; 13 Fillman (B24) 2013; 18 Slifstein (B79) 2015; 72 Bramon (B9) Chen (B13) 2018; 564 Zhang (B94) 2020; 13 |
| References_xml | – volume: 347 start-page: 1260419 year: 1979 ident: B85 article-title: Proteomics. Tissue-based map of the human proteome publication-title: Science doi: 10.1126/science.1260419 – start-page: 1 volume-title: Neuropsychopharmacology ident: B96 article-title: A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits – volume: 117 start-page: 92 year: 2010 ident: B5 article-title: Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia publication-title: Schizophr. Res. doi: 10.1016/j.schres.2009.07.025 – volume: 117 start-page: 2687 year: 2004 ident: B30 article-title: Rab7 is required for the normal progression of the autophagic pathway in mammalian cells publication-title: J. Cell Sci. doi: 10.1242/jcs.01114 – volume: 10 start-page: 757 year: 2014 ident: B35 article-title: Ultrasensitive proteome analysis using paramagnetic bead technology publication-title: Mol. Syst. Biol. doi: 10.15252/msb.20145625 – volume: 13 start-page: 597391 year: 2020 ident: B43 article-title: Local secretory trafficking pathways in neurons and the role of dendritic golgi outposts in different cell models publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2020.597391 – volume: 10 start-page: 1 year: 2019 ident: B50 article-title: Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: Evidence from clinical neuroimaging studies publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2018.00767 – volume: 9 start-page: 397 year: 2015 ident: B37 article-title: Cytoplasmic dynein and its regulatory proteins in Golgi pathology in nervous system disorders publication-title: Front. Neurosci. doi: 10.3389/fnins.2015.00397 – volume: 13 start-page: 731 year: 2016 ident: B84 article-title: The Perseus computational platform for comprehensive analysis of (prote)omics data publication-title: Nat. Methods doi: 10.1038/nmeth.3901 – volume: 35 start-page: 660 year: 2012 ident: B22 article-title: Major histocompatibility complex class I proteins in brain development and plasticity publication-title: Trends Neurosci. doi: 10.1016/j.tins.2012.08.001 – volume: 102 start-page: 7910 year: 2005 ident: B57 article-title: Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0502206102 – volume: 11 start-page: 246 year: 2020 ident: B63 article-title: Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats publication-title: Nat. Commun. doi: 10.1038/s41467-019-14122-0 – volume: 41 start-page: E46 year: 2016 ident: B28 article-title: Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia publication-title: J. Psychiatry Neurosci. doi: 10.1503/jpn.150195 – volume: 41 start-page: 77 year: 2013 ident: B89 article-title: WEB-Based GEne SeT AnaLysis toolkit (WebGestalt): Update 2013 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkt439 – volume: 165 start-page: 1006 year: 2008 ident: B91 article-title: Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: Relationship with impaired cognition, behavioral disorganization, and global function publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2008.07060945 – volume: 147 start-page: 307 year: 1999 ident: B19 article-title: Analysis of dynactin subcomplexes reveals a novel actin-related protein associated with the Arp1 minifilament pointed end publication-title: J. Cell Biol. doi: 10.1083/jcb.147.2.307 – volume: 12 start-page: 1792 year: 2002 ident: B78 article-title: The Rab6 GTPase regulates recruitment of the dynactin complex to golgi membranes publication-title: Curr. Biol. doi: 10.1016/s0960-9822(02)01221-6 – volume: 10 start-page: 410 year: 2009 ident: B4 article-title: Stress signalling pathways that impair prefrontal cortex structure and function publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn2648 – volume: 9 start-page: 147 year: 2019 ident: B8 article-title: DLPFC transcriptome defines two molecular subtypes of schizophrenia publication-title: Transl. Psychiatry doi: 10.1038/s41398-019-0472-z – volume: 15 start-page: 73 year: 2008 ident: B70 article-title: Banco de tejidos neurológicos de Sant Joan de Déu-Serveis de Salut Mental para la investigación de las enfermendades mentales. La importancia de un programa de donación en vida publication-title: Psiquiatr. Biol. doi: 10.1016/S1134-5934(08)71126-6 – start-page: e0155631 volume-title: PLoS One ident: B23 article-title: Peripheral immune cell populations associated with cognitive deficits and negative symptoms of treatment-resistant schizophrenia – volume: 6 start-page: 5 year: 2020 ident: B60 article-title: Post-translational protein modifications in schizophrenia publication-title: npj Schizophr. doi: 10.1038/s41537-020-0093-9 – volume: 167 start-page: 686 year: 2010 ident: B29 article-title: International consensus study of antipsychotic dosing publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2009.09060802 – volume: 72 start-page: 316 year: 2015 ident: B79 article-title: Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia a positron emission tomographic functional magnetic resonance imaging study publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2014.2414 – volume: 69 start-page: 4093 year: 2012 ident: B51 article-title: Are Rab proteins the link between Golgi organization and membrane trafficking? publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-012-1021-6 – volume: 564 start-page: 71 year: 2018 ident: B13 article-title: PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation publication-title: Nature doi: 10.1038/s41586-018-0761-3 – volume: 121 start-page: 46 year: 2010 ident: B21 article-title: Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8 publication-title: Schizophr. Res. doi: 10.1016/j.schres.2010.05.014 – volume: 52 start-page: 544 year: 1995 ident: B62 article-title: Increased rate of P300 latency prolongation with age in schizophrenia: Electrophysiological evidence for a neurodegenerative process publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1995.03950190026004 – volume: 290 start-page: 28613 year: 2015 ident: B81 article-title: Actin out: Regulation of the synaptic cytoskeleton publication-title: J. Biol. Chem. doi: 10.1074/jbc.R115.655118 – volume: 14 start-page: 274 year: 2020 ident: B16 article-title: The inflamed brain in schizophrenia: The convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2020.00274 – volume: 12 start-page: 363 year: 2022 ident: B47 article-title: Ninna Vihrs 6. Jesper Møller et al. Layer III pyramidal cells in the prefrontal cortex reveal morphological changes in subjects with depression, schizophrenia, and suicide publication-title: Transl. Psychiatry doi: 10.1038/s41398-022-02128-0 – volume: 13 start-page: 24 year: 2021 ident: B56 article-title: Neuro-immune aspects of schizophrenia with severe negative symptoms: New diagnostic markers of Disease phenotype publication-title: Sovrem. Tehnol. V. Med. doi: 10.17691/STM2021.13.6.03 – start-page: 421 volume-title: Nature ident: B9 article-title: Biological insights from 108 schizophrenia-associated genetic loci – volume: 10 start-page: 1 year: 2019 ident: B46 article-title: Constructing the immune signature of schizophrenia for clinical use and research; an integrative review translating descriptives into diagnostics publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2018.00753 – volume: 12 start-page: 939 year: 2009 ident: B44 article-title: Motivation and cognitive control in the human prefrontal cortex publication-title: Nat. Neurosci. doi: 10.1038/nn.2321 – volume: 18 start-page: 77 year: 2016 ident: B20 article-title: Dysregulations of synaptic vesicle trafficking in schizophrenia publication-title: Curr. Psychiatry Rep. doi: 10.1007/s11920-016-0710-5 – volume: 46 start-page: 616 year: 1999 ident: B49 article-title: Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia publication-title: Biol. Psychiatry doi: 10.1016/s0006-3223(99)00061-x – volume: 206 start-page: 4 year: 2019 ident: B41 article-title: Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis publication-title: Schizophr. Res. doi: 10.1016/j.schres.2018.12.017 – volume: 50 start-page: 169 year: 2001 ident: B45 article-title: Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia publication-title: Schizophr. Res. doi: 10.1016/s0920-9964(00)00156-0 – volume: 506 start-page: 179 year: 2014 ident: B27 article-title: De novo mutations in schizophrenia implicate synaptic networks publication-title: Nature doi: 10.1038/nature12929 – ident: B55 – volume: 81 start-page: 11703 year: 2007 ident: B72 article-title: Pol-specific CD8 + T cells recognize simian immunodeficiency virus-infected cells prior to nef-mediated major histocompatibility complex class I downregulation publication-title: J. Virol. doi: 10.1128/JVI.00926-07 – volume: 23 start-page: 6494 year: 2003 ident: B32 article-title: Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: Role of Rab7 and RILP publication-title: Mol. Cell Biol. doi: 10.1128/mcb.23.18.6494-6506.2003 – volume: 157 start-page: 2040 year: 2000 ident: B71 article-title: Exploring the social brain in schizophrenia: Left prefrontal underactivation during mental state attribution publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.157.12.2040 – volume: 18 start-page: 198 year: 2021 ident: B2 article-title: Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: Relationship with monoamines and symptomatology publication-title: J. Neuroinflamm. doi: 10.1186/s12974-021-02260-6 – start-page: 1 volume-title: Genes (Basel) ident: B15 article-title: Immune-related genomic schizophrenic subtyping identified in DLPFC transcriptome – volume: 27 start-page: 445 year: 2021 ident: B90 article-title: Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: Pathophysiological implications publication-title: Mol. Psychiatry doi: 10.1038/s41380-021-01092-3 – volume: 57 start-page: 289 year: 1995 ident: B92 article-title: Controlling the false discovery rate: A practical and powerful approach to multiple testing publication-title: J. R. Stadtstical Soc. doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 460 start-page: 3 year: 2009 ident: B17 article-title: Common variants conferring risk of schizophrenia publication-title: Nature doi: 10.1038/nature08186 – volume: 74 start-page: 555 year: 2010 ident: B42 article-title: A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction publication-title: Med. Hypotheses doi: 10.1016/j.mehy.2009.09.040 – volume: 121 start-page: 86 year: 2018 ident: B65 article-title: Nicotinamide Mononucleotide Adenylyltransferase 2 maintains neuronal structural integrity through the maintenance of golgi structure publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2018.09.010 – volume: 276 start-page: 37692 year: 2001 ident: B68 article-title: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M105927200 – volume: 9 start-page: 4593 year: 2018 ident: B80 article-title: Tissue-resident memory T cells populate the human brain publication-title: Nat. Commun. doi: 10.1038/s41467-018-07053-9 – volume: 11 start-page: 35 year: 2021 ident: B53 article-title: Golgi-associated Rab GTPases implicated in autophagy publication-title: Cell Biosci. doi: 10.1186/s13578-021-00543-2 – volume: 17 start-page: 623 year: 2020 ident: B75 article-title: Schizophrenia-associated MicroRNA – gene interactions in the dorsolateral prefrontal cortex publication-title: Genomics Proteomics Bioinforma. doi: 10.1016/j.gpb.2019.10.003 – start-page: e0149314 volume-title: PLoS One ident: B93 article-title: RAB-6.1 and RAB-6.2 promote retrograde transport in C. elegans – volume: 52 start-page: 304 year: 2019 ident: B95 article-title: Neuronal function and dysfunction of CYFIP2: From actin dynamics to early infantile epileptic encephalopathy publication-title: BMB Rep. doi: 10.5483/BMBRep.2019.52.5.097 – volume: 13 start-page: S20 year: 2012 ident: B39 article-title: GLAD4U: Deriving and prioritizing gene lists from PubMed literature publication-title: BMC Genomics doi: 10.1186/1471-2164-13-S8-S20 – start-page: 267 volume-title: Handbook of neurochemistry and molecular neurobiology: Schizophrenia year: 2009 ident: B40 article-title: Synaptic vesicle associated proteins and schizophrenia doi: 10.1007/978-0-387-30410-6_7 – volume: 62 start-page: 711 year: 2007 ident: B3 article-title: Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.12.021 – volume: 16 start-page: 519 year: 2020 ident: B18 article-title: Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment publication-title: Neuropsychiatric Dis. Treat. doi: 10.2147/NDT.S225643 – volume: 13 start-page: 1102 year: 2008 ident: B64 article-title: Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4002098 – volume: 28 start-page: R471 year: 2018 ident: B69 article-title: Rab GTPases and membrane trafficking in Neurodegeneration publication-title: Curr. Biol. doi: 10.1016/j.cub.2018.02.010 – volume: 8 start-page: 81 year: 2014 ident: B1 article-title: CYFIP family proteins between autism and intellectual disability: Links with fragile X syndrome publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2014.00081 – volume: 29 start-page: 159 year: 2020 ident: B31 article-title: A transcriptome-wide association study implicates specific pre-and post-synaptic abnormalities in schizophrenia publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddz253 – volume: 15 start-page: 90211 year: 2019 ident: B48 article-title: R2‐P2 rapid‐robotic phosphoproteomics enables multidimensional cell signaling studies publication-title: Mol. Syst. Biol. doi: 10.15252/msb.20199021 – volume: 18 start-page: 206 year: 2013 ident: B24 article-title: Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia publication-title: Mol. Psychiatry doi: 10.1038/mp.2012.110 – volume: 20 start-page: 424 year: 2015 ident: B26 article-title: Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia publication-title: Mol. Psychiatry doi: 10.1038/mp.2014.63 – volume: 53 start-page: 43 year: 2021 ident: B7 article-title: Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis publication-title: Ann. Med. doi: 10.1080/07853890.2020.1814962 – volume: 9 start-page: 41 year: 2008 ident: B82 article-title: Dysfunctional GABAergic inhibition in the prefrontal cortex leading to ‘psychotic’ hyperactivation publication-title: BMC Neurosci. doi: 10.1186/1471-2202-9-41 – volume: 52 start-page: 127 year: 2005 ident: B14 article-title: Interferon-γ inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells publication-title: Glia doi: 10.1002/glia.20232 – volume: 16 start-page: e1008821 year: 2020 ident: B36 article-title: Innate, non-cytolytic CD8 + T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1008821 – volume: 14 start-page: 30 year: 2002 ident: B34 article-title: Trafficking of MHC class II molecules in the late secretory pathway publication-title: Curr. Opin. Immunol. doi: 10.1016/s0952-7915(01)00295-3 – volume: 12 start-page: 728990 year: 2021 ident: B74 article-title: Is elevated neutrophil count and neutrophil-to-lymphocyte ratio a cause or consequence of schizophrenia?—a scoping review publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2021.728990 – volume: 347 start-page: 1441 year: 1979 ident: B86 article-title: The structure of the dynactin complex and its interaction with dynein publication-title: Science doi: 10.1126/science.aaa4080 – volume: 21 start-page: 1090 year: 2016 ident: B25 article-title: Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume publication-title: Mol. Psychiatry doi: 10.1038/mp.2015.90 – volume: 8 start-page: e2542 year: 2017 ident: B73 article-title: HIV-1 Nef is released in extracellular vesicles derived from astrocytes: Evidence for Nef-mediated neurotoxicity publication-title: Cell Death Dis. doi: 10.1038/cddis.2016.467 – volume: 25 start-page: 761 year: 2020 ident: B12 article-title: Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation publication-title: Mol. Psychiatry doi: 10.1038/s41380-018-0235-x – volume: 39 start-page: 528 year: 2014 ident: B59 article-title: N -glycosylation of gaba A receptor subunits is altered in schizophrenia publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.190 – volume: 7 start-page: 11932 year: 2016 ident: B61 article-title: Activation of STING requires palmitoylation at the Golgi publication-title: Nat. Commun. doi: 10.1038/ncomms11932 – volume: 167 start-page: 261 year: 2010 ident: B10 article-title: Prenatal infection and schizophrenia: A review of epidemiologic and translational studies publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2009.09030361 – volume: 19 start-page: 417 year: 2007 ident: B66 article-title: Neuroimaging of cognitive disability in schizophrenia: Search for a pathophysiological mechanism publication-title: Int. Rev. Psychiatry doi: 10.1080/09540260701486365 – start-page: 396 volume-title: Developmental neuroscience year: 2019 ident: B67 article-title: Golgipathies in neurodevelopment: A new view of old defects – volume: 13 start-page: 574947 year: 2020 ident: B94 article-title: Enhanced prefrontal neuronal activity and social dominance behavior in postnatal forebrain excitatory neuron-specific Cyfip2 knock-out mice publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2020.574947 – volume: 161 start-page: 889 year: 2004 ident: B11 article-title: Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.161.5.889 – volume-title: Human prefrontal cortex. Evolution, development, and pathology year: 2012 ident: B83 – volume: 142 start-page: 18 year: 2020 ident: B38 article-title: Meta-analysis of total and differential white blood cell counts in schizophrenia publication-title: Acta Psychiatr. Scand. doi: 10.1111/acps.13140 – volume: 123 start-page: 45 year: 2014 ident: B52 article-title: The neural and genetic basis of executive function: Attention, cognitive flexibility, and response inhibition publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2013.08.007 – volume: 5 start-page: 42 year: 2007 ident: B76 article-title: Positive and negative syndrome scale as a long-term outcome measurement tool in patients receiving clozapine ODT: A pilot study publication-title: Pharm. Pract. (Granada) doi: 10.4321/s1886-36552007000100007 – volume: 340 start-page: 577167 year: 2020 ident: B6 article-title: Aspects of the immune system that impact brain function publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2020.577167 – volume: 79 start-page: 481 year: 2017 ident: B54 article-title: Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2017.08.005 – volume: 30 start-page: 163 year: 2002 ident: B33 article-title: PharmGKB: The pharmacogenetics Knowledge Base publication-title: Nucleic Acids Res. doi: 10.1093/nar/30.1.163 – volume: 168 start-page: 276 year: 2011 ident: B87 article-title: Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2010.09081215 – volume: 46 start-page: 374 year: 2020 ident: B88 article-title: Synapse pathology in schizophrenia: A meta-analysis of postsynaptic elements in postmortem brain studies publication-title: Schizophr. Bull. doi: 10.1093/schbul/sbz060 – volume: 64 start-page: 40 year: 2009 ident: B77 article-title: MHC class I: An unexpected role in neuronal plasticity publication-title: Neuron doi: 10.1016/j.neuron.2009.09.044 – volume: 5 start-page: 267 year: 2002 ident: B58 article-title: Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia publication-title: Nat. Neurosci. doi: 10.1038/nn804 |
| SSID | ssj0000399364 |
| Score | 2.3148477 |
| Snippet | The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1003557 |
| SubjectTerms | DLPFC immune system molecular network Pharmacology postmortem schizophrenia |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fS-QwEA7iky9yp95dz1MiyL5osU3TtPFNRRHBY5Fd8C3kJy5Id3FXuP3vnWm6664cdy--lTZJQ2aSmSHffEPIsQOrbXKepyHUOuUBwh0NZ3HKdM49lxb2OiYK3_8Wt0N-91g-rpT6QkxYpAeOC3dWCul0YQqHpJdM19qVxnLHZOkzEUzLBJrJbCWYas9gtLuCxywZiMLkWZg8aeT_ZAUCA8DKVmuWqCXs_5uX-REsuWJ9br6Q7c5tpBdxul_Jhm92SK8feafnp3TwnkY1PaU92n9npJ7vkvmCeoSOA20i8HtKRw0F74-6MZbM1piJ_EwnME2kNIBHizDcP9jKRgJdOl0F6J3TB0xNR6XBUdtbd-_oCPNNPH2J0Fu_R4Y314Or27SruZBaCJRnaSm5kbXTYPW1hfBG27zywkiWe2ZZ7kwWwLwx7soi87oOeRm0tni3GlxlhCu-kc1m3PgfhJrSZXUQEDPBoEJWxllw6DLLas0cdEtIvlh_ZTtCcqyL8awgMEGZqVZmCmWmOpkl5GTZZxLpOP7Z-hLFumyJVNrtC1Aw1SmY-p-CJeRooRQKth7ep-jGj1-nilXoXMtKioR8j0qy_FUBJ2kB3l1C6jX1WZvL-pdm9NTSeyNuRYCb_fMzZr9PtnBFEDXHil9kc_by6g_AjZqZw3bHvAF-miCN priority: 102 providerName: Directory of Open Access Journals |
| Title | Analysis of networks in the dorsolateral prefrontal cortex in chronic schizophrenia: Relevance of altered immune response |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37033658 https://www.proquest.com/docview/2799169796 https://pubmed.ncbi.nlm.nih.gov/PMC10076656 https://doaj.org/article/569da3b3d74842a8ad5bc4d295e06fb4 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ra9RAEB9qBekX8W18lBWkX2w02SSbrCCiYilCpUgP-i3s0x4cyXm5Qu-_d2aTXO-k9VtINpvHzOQ3k535DcBbi6it0zyNva9UnHsMdxR-i2Ou0tzl0qCtU6HwyU9xPMl_nBfnOzC2OxpeYHdjaEf9pCaL2furP6vPaPCfKOJEvP3g5xeKqD15Rmv-CKDlHbiLyCQoGDsZ3P3wZSY0DoxSKQJtLBHc-jqaW6bZg3sZWkQmqCH8BmwFdv-bXNJ_Mys3oOroAdwffEz2pVeKh7DjmkdwcNqTVK8O2dl1zVV3yA7Y6TV99eoxrEaeEtZ61vRZ4h2bNgxdRWZb6q-tqGx5xuZ4m8R_gJuGcnavaJTp2XZZt5nN95H9ojp20jCaNSzRO8umVJzi2KLP03VPYHL0_ezbcTw0aIgNRtXLuJC5lpVV6CIog7GQMmnphJY8ddzw1OrEIxby3BZZ4lTl08IrZWgh1ttSC5s9hd2mbdxzYLqwSeUFBlg4qZCltga9v8TwSnGLp0WQju-_NgN7OTXRmNUYxZD46iC-msRXD-KL4N36nHnP3fHf0V9JrOuRxLsddrSL3_VgxnUhpFWZzixRsHJVKVtok1suC5cIr_MI3oxKUaOd0uKLalx72dW8JE9cllJE8KxXkvWlRiWLoNpSn6172T7STC8CFzgluQj0yV_cOulL2KPHpLw5nr2C3eXi0r1GR2qp98MPiP1gI38BPY8eRg |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+networks+in+the+dorsolateral+prefrontal+cortex+in+chronic+schizophrenia%3A+Relevance+of+altered+immune+response&rft.jtitle=Frontiers+in+pharmacology&rft.au=Vera-Montecinos%2C+Am%C3%A9rica&rft.au=Rodr%C3%ADguez-Mias%2C+Ricard&rft.au=Vila%2C+%C3%88lia&rft.au=Vill%C3%A9n%2C+Judit&rft.date=2023-03-23&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=14&rft.spage=1003557&rft_id=info:doi/10.3389%2Ffphar.2023.1003557&rft_id=info%3Apmid%2F37033658&rft.externalDocID=37033658 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |